Please login to the form below

Not currently logged in
Email:
Password:

therapy watch

This page shows the latest therapy watch news and features for those working in and with pharma, biotech and healthcare.

New biosimilars group will tackle slow uptake in UK

New biosimilars group will tackle slow uptake in UK

Despite being around for several years in Europe, the awareness of biosimilars remains fairly low - with a survey carried out in 2014 by Therapy Watch finding just 8% of EU physicians

Latest news

  • Creating a brand identity for biosimilars Creating a brand identity for biosimilars

    Only 8 per cent of EU physicians spontaneously mentioned biosimilars as products in development in a recent survey by Therapy Watch, and only 35 per cent said they would definitely consider

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • The evolving biosimilars market The evolving biosimilars market

    Although these key regulatory developments are expected to greatly facilitate the approval of biosimilars in the near future, recent research from Research Partnership's Therapy Watch revealed that only 47% of

  • Pharma deals in April 2015 Pharma deals in April 2015

    Watch this space!  . Gene Therapy. After years of promise and failing to deliver, gene therapy companies are back in favour. ... No deal terms were disclosed. The initial development plan will look at the combination therapy as a potential treatment for

  • Biosimilars: friend or foe for healthcare systems? Biosimilars: friend or foe for healthcare systems?

    As the Therapy Watch data indicates, though, many believe the decision will ultimately be taken out of their hands. ... Fleetwood is director of Therapy Watch at the Research Partnership and can be contacted on tel: 44 208 0695049 or email her.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Research Partnership appoints new directors Research Partnership appoints new directors

    th. anniversary.”. “Having worked with Anne previously as a client of our syndicated market-tracking tool Therapy Watch, it’s great to now be able to welcome her to our

  • Helen Parfitt joins Research Partnership Helen Parfitt joins Research Partnership

    She takes on role as head of its Therapy Watch market tracking tool. ... I believe she will be a strong asset to the Therapy Watch team and we look forward to her contributing to its continued growth and development.”.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 15 fully matching, plus 19 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics